Members' News

8 Sep 2022

HM Queen Elizabeth II (1926-2022)

We are saddened by the death of Her Majesty Queen Elizabeth II.

30 Aug 2022

aTen Therapeutics to develop new breast cancer treatment

aTen Therapeutics awarded £282k to develop new breast cancer treatment 

8 Aug 2022

BioIVT Acquires Cypex, a Leading Manufacturer of Drug-metabolizing Enzymes

Cypex’s recombinant xenobiotic metabolizing enzymes complement BioIVT’s extensive portfolio of hepatocytes and related hepatic products for drug research and development

4 Aug 2022

RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO

The RoslinCT-Lykan combination creates an innovative advanced therapies contract development and manufacturing organization (CDMO) with process and analytical development laboratories and cGMP manufacturing facilities l…

26 Jul 2022

SLA response to the Government consultation on future strategy for testing and release of medicines

For the SLA response to the Government consultation on future strategy for testing and release of imported medicines please click here.

22 Jun 2022

Cyclacel Pharmaceuticals Elects Kenneth M. Ferguson, Ph.D. to Its Board of Directors

BERKELEY HEIGHTS, N.J., June 22, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on c…

8 Jun 2022

RoslinCT continues its growth plans by expanding its operations at Edinburgh Technopole

Edinburgh, UK, 08 June 2022 – RoslinCT - a cell and gene therapy/ATMP CDMO, developing life-changing cell and gene therapies in Edinburgh’s BioQuarter– signs lease for 1,453 sqm additional space at Charles Darwin House …

8 Jun 2022

Tepnel: Establishment of Employee Ownership Trust

Tepnel, a Scottish Pharma Services Company, based in Livingston, Scotland, announces the completion of the sale of the business to Tepnel Life Sciences Trustees LImited.

21 Apr 2022

NovaBiotics Announces Presentations of New Data for NM002 and NP339

11 Apr 2022

Life Sciences Start-up Report now available through WAPG

The report, written by Glen Crocker of both We are Pioneer Group and JLL is now available from the link here: https://www.wapg.co/reports/

8 Apr 2022

Medannex presents data on MDX-124

Medannex’s first-in-class agent shows significant activity against clinically challenging cancers

17 Mar 2022

Scottish biotech company ILC Therapeutics strengthens team to accelerate development of Covid19 drug

Pioneering biotech company strengthened by senior appointments to bolster capabilities in research, product development and clinical trials. Company ready to accelerate the development of Alfacyte™ – ILC’s l…

8 Feb 2022

Scots pair partner on device to develop medicines and reduce antibiotic resistance

Two independent Scottish companies have come together to speed up the development of medicines, vaccines, and key ingredients for reducing antibiotic resistance.

21 Jan 2022

Medannex: monoclonal antibody MDX 124 highly active in pancreatic cancer models

Medannex’s monoclonal antibody MDX-124 highly active in pancreatic cancer models

12 Jan 2022

Apposite Capital-backed Kelso Pharma acquires Stirling Anglian Pharmaceuticals

PRESS RELEASE